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Rationale and practical techniques for mouse
models of early vein graft adaptations
Peng Yu, MD, Binh T. Nguyen, MD, Ming Tao, MD, Christina Campagna, BS, and
C. Keith Ozaki, MD, Boston, Mass
Mouse models serve as relatively new yet powerful research tools to study intimal hyperplasia and wall remodeling of vein
bypass graft failure. Several model variations have been reported in the past decade. However, the approach demands
thoughtful preparation, selected sophisticated equipment, microsurgical technical expertise, advanced tissue processing,
and data acquisition. This review compares several described models and aims (building on our personal experiences) to
practically aid the investigators who want to utilize mouse models of vein graft failure. ( J Vasc Surg 2010;52:444-52.)
Clinical Relevance: Surgical revascularization via vein grafting offers immediate and often dramatic end organ benefit.
However, substantial percentages of vein conduits placed develop stenosis or fail, often early. Mechanistic studies of the
complex interplay between the biologic and physical forces that drive failure have been hampered by limited quantity and
quality of clinical specimens, and the inability of systems such as computer models and cell culture to mimic the clinical
circumstance. This review summarizes the power and limitations of mouse vein graft models, and it includes practical
experience-based advice for researchers aiming to utilize this tool.Surgical bypass via autologous vein stands as an
evidence-based treatment of choice for selected patients with
infrainguinal lower extremity or coronary occlusive dis-
ease;1 thus, over half a million vein grafts are implanted
annually in theUnited States. However, contemporary data
show that almost 40% of lower extremity vein bypass grafts
develop occlusive lesions or fail within a year,2 and almost half
of cardiac bypass patients will lose (75% stenosis) a vein graft
within a year.3 These failures result in recurrent end-organ
ischemia, complex (and expensive) redo revascularizations,
and not infrequently loss of human limb or life.
Intimal hyperplasia and negative (inward) vein graft
wall remodeling are the main culprits of vein bypass graft
failure. The former has been intensively studied for de-
cades,4-6 while the latter has only recently triggered re-
search interest.7,8 Since arterialized vein conduit tissue is
rarely retrieved from patients, and due to the inability of
contemporary cell and tissue culture approaches to mimic
the multifactorial events of early vein graft failure, animal
models serve as an essential tool to explore the mechanisms
of vein graft adaptations.
There are many animal models that simulate arteri-
alized venous bypass graft failure, eg, murine,9-15 rat-
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444tus,16 rabbit,17,18 canine,19 porcine,20 monkey,21,22 and
baboon.23 Since the development of knockout and trans-
genic techniques, the use of mice in vascular research has
boomed over the last two decades. With these ap-
proaches, researchers have tools to study the in vivo
function of a specific gene product, while avoiding the
difficulties associated with the use of antibodies or recep-
tor agonists/antagonists (such as nonspecificity, immu-
noreactivity, dosing and tachyphylaxis). Additionally,
the vein bypass graft model in mice also serves as a
platform to test the influences of factors such as diseases,
inflammatory states, and hemodynamic changes on vein
graft wall adaptations.
This review will summarize the advantages and draw-
backs to current mouse models of vein graft adaptations
(Table I), compare the technical variations in mouse vein
graft constructions, and provide a practical guide for utili-
zation of this species for surgical vein bypass investigations.
Investigators interested in exploring the use of animals for
research should familiarize themselves with federal laws
(the Animal Welfare Act of 1966 and its amendments), the
Guide for the Care and Use of Laboratory Animals (Na-
tional Research Council), NIH Animal Research Advisory
Committee Guidelines,24 and appropriate local laboratory
animal welfare guidelines.
GENERAL TECHNICAL CONSIDERATIONS
Like most mammalian models of vascular diseases, in
vivo mouse studies hold many confounding factors that
contribute to observed variations in the vein graft adapta-
tions (eg, amount of intimal hyperplasia), although most of
these are not well documented for mice in the formal
research literature. In our experiences, these include the
surgeon’s technical skills, the level of sterility within the
operative field and subsequent local/systemic infection and
inflammation, procedural time, ischemia time of the vein
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tion or over-stretching of the vein or recipient artery, etc.),
artery clamp times and end-organ ischemia (especially for
aorta and common femoral artery models), total blood/
fluid loss and replacement, and usage of heparin, etc.
Among these, the surgeon’s technique (especially minimi-
zation of physical vein endothelial trauma and the variation
of hand-sewn anastomotic diameter) and ischemia/desic-
cation of the vein segment appear to be major contributors
to the variability in early vein graft wall adaptations. For the
novice microsurgeon attempting to master these complex
models, it is recommended that practice time be completed
to reach the plateau phase of the learning curve prior to
engaging in any formal studies. The actual individual inves-
tigator’s time to approach the learning curve plateau is
quite variable (estimated 20-60 surgeries) and depends
largely on the training environment and learner’s original
level of microsurgical technique.
Equipment. Basic microsurgical equipment is required
for successful completion of these models. This includes an
environment-controlled laboratory facility with a stable
table and chair, autoclave/dry sterilizer, a set of high-
quality, well-maintained microsurgical instruments, 5-0
to 12-0 sutures, and an operating microscope with high-
intensity operating lights. The high-quality microsurgi-
cal operating microscope stands as a central component
to the equipment. We utilize a Zeiss binocular, dual-
headed OPMI-MD surgical microscope on S-5 Floor
Stand (Carl Zeiss Inc, Germany), with T2 digital SLR
camera/camcorder system (Fig 1, A). The magnification
can be altered from 4-fold up to 24-fold. X-Y-Z adjustable
foot control aids in precision and sterility, and a large depth
of field (which is absent on some dissecting microscopes) is
Table I. Mouse vein graft model advantages/disadvantag
Advantages
● The most commonly used mammalian model organism, with a
robust existing literature
● Advanced genetics (mouse genome has been sequenced) and
array of mice available
● Established models of human disease, such as
hypercholesterolemia, diabetes, and obesity
● Less sentient than other available animal vein graft models
● Relatively similar to humans in anatomy, physiology, and
genetics
● Technological advances allow physiologic monitoring, such as
flow rate and blood pressure monitoring
● Small, easy to maintain and handle, low housing costs
● Have a short generation time, reproduce quickly and prolific
● Low doses/volumes required for test solutions (eg, antibodies,
gene therapy vehicles, pharmacologic compounds)
● Wide availability of reagents for use with murine tissueuseful.Intraoperative strategies. The surgical procedure
should be performed under aseptic conditions. Mouse skin
preparation (hair removal and scrubbing with povidone-
iodine or other disinfectants) and sterile draping (Fig 1, A)
are suggested.
Utilization of heparin is variable in published reports.
We utilize heparinized saline (100 IU/mL) as flush solu-
tion only. Fixed positioning of the inflow and outflow
artery ends can be achieved by microsurgical approximator
clamps or simply securing two Micro Clips (Roboz Inc,
Gaithersburg, Md) via a double-looped (easily adjustable)
4-0 suture around the clip handles.
Immediately after vein graft construction, patency can
be determined by the pulsation of vein graft and distal
artery, blood flow observation through the thin vein graft
wall, gentle empty-and-refill (strip) test on the inflow or
outflow artery (not recommended on the vein graft), and
intraoperative flowmetry (we utilize a Transonic TS420
flowmeter with 1PRB flowprobe, Transonic Systems Inc.,
Ithaca, NY) or ultrasonography.11 Simple judgment by
turgidity of the vein graft is not reliable.
Perioperative strategies for anesthesia and analg-
esia. Since vein graft placement is a major survival surgery
with prolonged operative time, use of a continuous inhal-
ant anesthesia system (eg, isoflurane via a calibrated vapor-
izer, with scavenging devices) is recommended rather
than injectable approaches. Some researchers employ an
“open”, noncalibrated method (bell jar or nose cone),
which presents a challenge when attempting to control the
agent concentration and anesthetic depth. Frequent mon-
itoring of physiologic parameters such as respiratory rate
and pain reflex is crucial. Prevention of hypothermia (via
37°C heating pad and lamp) and perioperative systemic
Disadvantages
● Many murine models are new and lack a long-standing track
record
● As with all nonhuman research, applicability to the human
situation may be limited
● Monitoring and measuring may lack resolution in small
mammals
● Small-scale instruments and monitoring devices can be
relatively expensive
● Surgical procedures can be difficult to complete and reliably
reproduce due to the small size of the murine vasculature
● Available tissue quantities for assays are small
● Limited volume of intimal hyperplasia in wild-type mice can
make identification of preventative therapies difficult
● Antibodies are often of murine originesfluid therapy minimizes anesthesia-related complications
ith h
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as glycopyrrolate or atropine) to reduce secretions in the
respiratory tract is recommended, and we administer an
analgesic agent (buprenorphine) at the time of surgical
recovery and via schedule for 48 hours postoperatively.
MOUSE VEIN BYPASS GRAFT MODELS
Cuff technique for interposition graft. Zou et al9
first described a mouse vein graft model completed by the
cuff technique, which has been adopted or modified by
several research groups (Fig 1).25-30 In brief, the right
common carotid artery was gently mobilized free from
surrounding connective tissues as far distally and proximally
as possible. It was then ligated with sutures at the midpoint
and divided. After controlling the inflow and outflow arter-
ies via clamps placed at the premade polyethylene cuffs’
handles, the ligatures were removed, and the proximal and
distal artery ends were everted over the tubular body por-
tion of the cuffs, which had a 0.65-mm outside diameter
(OD) and a 0.5-mm inside diameter (ID). The vein seg-
ment (from separate donor supradiaphragmatic inferior
vena cava (IVC) or autologous external jugular vein) was
then sleeved over the artery cuffs and secured into position
with fine ties (as shown in Fig 1, B, C, and D). Mortality
rate has been reported as 5.3%; patency rate at harvest time
achieved 100%. Mean intima and media thickness (day 28,
male C57BL/6 mice) was 215 m, though our group
has not observed as thick of a vein graft wall with this
approach (we observe typically about 50 m average inti-
Fig 1. Cuff-technique mouse vein graft model. A, An
microscope and table-top small animal anesthesia system.
graft model. C, Two everted and secured carotid artery
E, Hand-made polyetheretherketone anastomotic cuff wmal thickness and 100 m average wall thickness).Cuff selectionmay be an important factor in this model.
Zou chose polyethylene tubing (OD, 0.65 mm; ID, 0.5
mm) for 3-month-old mice. We find this material to be
relatively soft and easy to distort if uneven force is exerted
during artery eversion. The size is also relatively large for
our 8-10-week-old (20-24 grams)mice. Diao et al reported
carotid ID at 0.35  0.02 mm (8-10-week-old, male
C57BL/6J mice);14 we also reported a similar result.31 For
the cuff material, we prefer an autoclavable polyetherether-
ketone extruded tubing (OD, 0.51 mm; ID, 0.41 mm;
from Zeus Inc, Orangeburg, SC) (Fig 1, E).
Finally, 9-0 monofilament nylon suture performs well
for ties, and 6-0 vicryl (Ethicon Inc, Somerville, NJ) for
incision closure.
Hand-sewn techniques for interposition graft.
Using an end-to-side anastomotic method, Zhang et al11
transplanted a 10-mm-long donor’s IVC segment to a
recipient’s common carotid (both from 17-20 grams male
C57BL/6J mice) and secured each anastomosis with 8 to
12 continuous stitches of 11-0 nylon suture. The carotid
segment between the IVC anastomoses was then ligated at
both ends and cut. Operative time averaged around 20
minutes for IVC harvest and 90 minutes for carotid inter-
position grafting. Mortality rate was10%, with a reported
patency rate of 95%. Mean wall (medial  neointimal)
thickness (day 28) was 91 m.
Cooley12,32 described a more delicate autograft model.
Under60 magnification, a branch of the external jugular
vein (2 mm in length) was dissected and transplanted into
ple of a rodent survival operating suite with operating
hematic representation of the cuff-technique vein bypass
. D, Completed mouse carotid interposition vein graft.
andle.exam
B, Sc
endsthe femoral artery using 6 to 10 interrupted stitches of 11-0
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ity rate was 15.9%, with patency rate at 81% on day 30.
Mean wall thicknesses were 103 m (proximal), 49 m
(middle), and 58 m (distal).
Grafts to the abdominal aorta have also been reported.
Diao et al14 transplanted a 5-mm-long external jugular vein
segment into autologous infrarenal aorta. Six or seven
interrupted 11-0 nylon stitches at each end-to-end anasto-
motic site were employed. With this model, average aorta
clamping time for male C57BL/6J mice was 68 minutes.
Mortality rate was 11.4%; patency rate on day 28 was 100%,
and mean wall thickness (day 28) appeared to be 60 m
(calculated from their representative images and graph).
Finally, Salzberg et al15 utilized a similar end-to-end
model but from the donor’s IVC to the recipient’s infrare-
nal abdominal aorta. Average aorta clamping time for male
C57BL/KsJ mice was 30 minutes. Mean neointimal thick-
ness (1 month postoperation) for this strain appeared to be
60 m based on their data and representative images.
Hand-sewn technique for vein patch. In an attempt
to mimic the events of the early vein conduit or an endar-
terectomy reconstruction33-36 and building on a method
employed in larger animals,37 Shi and colleagues10 de-
scribed a vein patch as a surrogate for vein graft tissue. They
harvested a5-mm-long external jugular vein (from 7-12-
week-old male C57 BL/6 mice), cut open the conduit and
trimmed it into an oval shape, and then used the patch to
repair a surgically created defect in the ipsilateral carotid
artery by a hand-sewn technique with 11-0 continuous
suturing. The average time from venous patch harvest to
common carotid artery reparation took about 40 minutes.
The overall success rate was 92%. From the reported repre-
sentative images, this model could induce obvious neointi-
mal formation and wall thickening (day 20). Sakaguchi and
associates13 have reported an application of this technique
to create a model that used a jugular patch to repair an
abdominal aorta defect.
Table II summarizes the comparison of these mouse
vein graft models, drawing upon the currently published
literature and our personal microsurgical experiences (in-
Table II. Comparison of common mouse vein graft mode
Zou’s9 (cuff
technique, IVC or
jugular to carotid,
end to end)
Zhang’s11 (se
IVC to caro
end to side
Technical challenge  
Relative procedure duration  
Extensive bleeding risk  
Risk of thrombosis  
Relative mortality  
Reproducibility  
Clinical relevance  
Other considerations Foreign body (cuff)
response at ends
IVC, Inferior vena cava.cluding over 400 mouse vein grafts).MODEL VARIATIONS/MODIFICATIONS
Selection of a mouse strain and genetic back-
ground. Mouse strain has a significant impact on the
vascular response to injury, and this should be taken into
consideration when selecting a particular strain of mice for
study. While there exists limited information on differences
in susceptibilities to intimal hyperplasia38 or negative re-
modeling in mouse vein graft models, data obtained from
arterial studies may serve as a useful baseline.39,40
One of the advantages of working with mice is the vast
array of transgenic and knockout animals available that
simulate and facilitate understanding of human diseases.
For example, ApoE-deficient mice were utilized to study
hypercholesterolemia,41 while leprdb/db mice served as a
model for type 2 diabetes mellitus.15 These genetic back-
grounds can be combined with themouse vein graft models
to provide a wealth of information about the mechanisms
of vein graft failure in different pathological settings.
Adjunctive hemodynamic manipulations. In addi-
tion, hemodynamic manipulations can also be utilized to
study the influence of pressure and flow perturbations on
vein graft adaptation. Wall tension is known to impact vein
graft wall adaptations,42,43 but largely due to their small
size, invasive pressure measurements along mouse vein
graft constructions have not proved reliable to date.
Conversely, flow manipulations in the mouse vein graft
model have been reported. The mouse distal common
carotid artery has two major branches, the internal carotid
and external carotid. In addition to the presence of
branches, they may be distinguished by size, with the
internal carotid artery having a slightly larger diameter than
the external carotid artery. The occipital artery, a small
branch originating from the external carotid or the bifur-
cation, travels with the internal carotid. The superior thy-
roid artery is a very small branch arising from the external
carotid artery (Fig 2).44
Osterberg and colleagues45 employed high-flow and
low-flow vein graft models (cuff technique) with 26-36
grams male C57BL/6 mice. By ligating the contralateral
Cooley’s12
(sewn, jugular
to femoral
artery, end to
end)
Diao’s14 and
Salzberg’s15 (sewn,
jugular or IVC to aorta,
end to end)
Shi’s10 and
Sakaguchi’s13 (vein
patch technique,
jugular to carotid
or aorta)
  
  
  
  
  
  
  
Short vein graft
(2 mm)
Low neointimal volume Not true vein graftls
wn,
tid,
)common carotid artery, they were able to induce a 20%
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1.0 mL/min) immediately after ligation, and a 1.1 mL/
min average value at day 42 in the high-flow group. With
ligation of the ipsilateral external carotid artery in the
low-flow group, a 50% immediate decrease in flow rate was
achieved, and it became 0.4 mL/min at day 42. The
neointimal area in the low-flow grafts was 74% larger than
that of high-flow mice at day 42, with mean intimal thick-
ness of 55 m vs 33 m, respectively (calculated from
graphs in their report).
Manipulation of vein graft wall shear stress changes vein
graft neointimal hyperplasia.46,47 We have completed vari-
ous ligations of carotid branches to alter the flow rate.
Ligation of the internal carotid artery plus occipital artery
yielded an immediate 52% decrease in flow rate (1.18 
0.14 mL/min vs 0.57 0.08 mL/min, control vs ligation,
respectively) and a 73% decrease (1.31  0.06 mL/min vs
0.36  0.04 mL/min) at harvest (day 28). This method
increased intimal thickness by 33% (50.2  3.3 m vs
66.9 4.9 m, Fig 3,A vs Fig 3, B, respectively). Ligation
of both the external and internal carotid artery (leaving only
the occipital artery patent) resulted in an immediate mean
flow rate 0.1 mL/min (n  6). However, this led to a
high rate of graft occlusion, as only one of three grafts were
patent at day 14, and three of three were occluded at day
28. The patent vein graft did show tremendous intimal
Fig 2. Mouse carotid artery anatomy and partial ligationmethods
(A, Photographed right carotid anatomy [cut surgical glove back-
ground ]. B, Schematic representation). a, Right common carotid
artery. b, Internal carotid artery. c, External carotid artery. d,
Occipital artery. e, Superior thyroid artery. (1), Ligation of exter-
nal carotid artery, including superior thyroid artery but not occip-
ital artery. (2), Ligation of internal carotid artery. (3), Ligation of
internal carotid artery plus occipital artery.hyperplasia (Fig 3, C).The above results demonstrate the importance of vari-
ous hemodynamic altering techniques for the wall adapta-
tion of vein grafts. Attempts to ligate only the external
carotid, only the internal carotid, or a combination of the
internal carotid plus occipital artery (Fig 2) produced lim-
ited flow decreases, and consequently, only modest intimal
hyperplasia was observed. Conversely, combining external
carotid and internal carotid artery ligation (with only oc-
cipital outflow) too severely restricted flow, with exorbitant
intimal hyperplasia, making this manipulation unpractical.
SPECIMEN PROCESSING AND ANALYSIS
CONSIDERATIONS
Financial and labor investments in complex mouse
surgical models are high, thus thoughtful and meticulous
specimen harvest and processing are paramount. Tissue
segments intended for frozen section histology or molecu-
lar analyses should be harvested fresh, although the frozen
method for optimal morphologic analysis of a vein graft is
not recommended because of the compromised anatomic
preservation. We prefer whole animal perfusion fixation (by
10% formalin or 4% paraformaldehyde) under physiologic
mean arterial pressure (100 mm Hg) with intravascular
access via the left ventricle or aortic arch. The right atrium
or supradiaphragmatic IVC can be cut as the outflow tract
of fixative fluid.
The intimal hyperplasia formation along the vein graft
is not uniform: it is usually the thickest at the proximal,
thinnest in the middle, and intermediate at the distal seg-
ment of the graft.11,12,14 This observation is also con-
firmed by our morphological analyses on serial cross-
sections (data not shown) and longitudinal sections (Fig
4) of the mouse vein grafts. Because of this variation,
meticulous localized sectioning and comparison of spe-
cific segments of the vein graft is important. Using a
landmark (such as cuff edges in cuff technique model or
anastomotic sutures in hand-sewn models), paraffin sec-
tions are obtained at 50-to 200-m intervals, and com-
puter image processing is employed to translate these
into quantified morphologic endpoints such as intimal
thickness, wall area, and lumen narrowing.
The microscopic anatomic definitions of mouse vein
graft wall and artery wall do not match very well. At least for
the common mouse strains that we have worked with
(C57BL/6J and B6129SF2/J), the only obvious elastic
lamina of the vein graft is recognized by us as the internal
elastic lamina because only a single (endothelial) cell layer
covers it (Fig 3, F), and -actin-positive cells appear beyond
it (Fig 3, G) in the wall of mouse IVC. The tunica media of
mouse vein graft could be obscure because of the early
smooth muscle cell loss45 but may still present in some
cases (Fig 3,H). The mouse vein graft wall does not have a
well-defined external elastic lamina, thus the evaluation of
the tunica media and tunica adventitia requires a different
method. Some authors utilize the vasa vasorum as a land-
mark to discern the interface between the media and ad-
ventitia.9,11 We find this is difficult since the vasa vasorum
may not always be present or associated with the true
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Volume 52, Number 2 Yu et al 449Fig 3. Masson trichrome staining (A-F) and -actin immunohistochemistry staining (G, H) of cross-sections of mouse
vein grafts/vein. Black arrows depict the internal elastic lamina (A-D, F-H); red arrows show the tunica adventitia/
perivascular tissue boundary (A-D); and green arrows show the vasa vasorum (H). A, Normal flow vein graft at day 28.
B,Vein graft with distal arterial partial (internal carotid occipital artery) ligation at day 28.C,Vein graft with distal arterial
partial (external carotid  internal carotid) ligation (leaving the occipital artery patent) at day 14. D, Negative wall
remodeling in amouse vein graft at day 28.E,Normal IVC.F,Enlarged area defined by the black box of Fig 3,E.G (normal
IVC) and H (mouse vein graft at day 28), note some rose-red or brownish-red positive expression of -actin in the tunica
media (beyond the internal elastic lamina).
intim
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adventitia has a relatively clear boundary with the surround-
ing looser connective tissue, it is not always round (as
shown in Fig 3, D) and should not be confused with the
external elastic lamina. To circumvent these issues, our
practice is to combine the “media  adventitia” layers for
morphological analysis.
Finally, similar to the clinical setting,8 positive or neg-
ative (Fig 3, D) vein graft wall remodeling can occur. A
single parameter, such as intimal area or thickness, cannot
adequately describe total wall adaptation. For example, the
grafts in Fig 3, B and Fig 3,D have similar intimal areas, but
there are obvious differences in intimal thickness. Thus,
histopathologic analysis of the vein graft tissue should not
be confined to just the intimal thickness or area but also
incorporate other parameters such as calculated ideal lumen
area, total wall thickness or area, length of the internal
elastic lamina in the perfusion-fixed section, and ratios
among these parameters.48
MOUSE VEIN GRAFT LIMITATIONS
Current mouse vein graft models hold disadvantages.
In most wild-type mice, there is limited neointimal forma-
tion, which hampers efforts to identify therapies to attenu-
ate intimal hyperplasia. Several possible reasons contribute
to this limitation. Our six-month mouse vein grafts did not
show exorbitant neointimal formation (data not shown),
and this suggests that simply extending the observation
period does not resolve this limitation.
Normal mouse IVC has a very thin wall (average wall
thickness is 12 m, distended with arterial pressure, from
male C57Bl/6J mice at age 9 weeks): one cell layer thick
tunica intima, one elastic lamina, just one or two cell layers
in the media adventitia (Fig 3, E, F, and G). This renders
early histologic evaluation extremely challenging.
Also, in mouse vein graft intimal hyperplasia, participa-
Fig 4. Masson trichrome staining of two longitudina
removed at ends, leading to artifact). Note variations intion of graft extrinsic cells appears to be significant. Acertain portion of neointimal cells and repopulated endo-
thelial cells originate from non-wall origin (such as bone
marrow),49-52 and we do not know if such processes occur
in the human scenario. Cells of various origins may respond
differently to therapeutic agents.
Comprehensive hemodynamic and biomechanical as-
sessments of the various mouse vein graft constructions
have not been reported. Thus, correlation with actual hu-
man physical parameters may be limited.
Finally, imaging also remains a challenge, although an
overall heightened interest in small animal imaging will
probably soon provide tools to gain in vivo anatomic and
biologic information in the mouse setting. For instance,
ctioned mouse vein grafts (cuff technique, cuffs were
al thickness along the length of the graft.
Fig 5. Upper left: Duplex ultrasound scanning of mouse right
carotid vein graft model (cuff technique), taken by Vevo 2100
Imaging System (VisualSonics Inc, Toronto, Canada). Red arrows
show vein graft wall. Lower: Velocity of vein graft blood flow.lly secommercially available high-frequency ultrasound duplex
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sions and blood velocities (Fig 5). Duplex potentially offers
a technically easy, noninvasive method for longitudinal
anatomic mouse vein graft imaging. However, published
reports that employ vascular imaging modalities for mouse
vein grafts are rare.
CONCLUSION
Despite the anatomical and physiologic differences be-
tween mice and men, and the inherent technical challenges
with small animal surgery, the mouse continues to serve as
an important stepping stone from laboratory bench work to
bedside practice. Knowledge of key advantages and limita-
tions of currently available mouse vein graft models will
help tailor experiments to systematically unlock mecha-
nisms that drive vein graft failure and challenge all to
improve on mouse-based investigative strategies to under-
stand vascular diseases.
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